Glaucoma Eye Care: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Glaucoma Eye Care
Largest movements
- Cash +€124,827
up €124,827 (+444.9%), from €28,056 to €152,883
mainly Net result for the year (+€211,089) and Tax, wage and social debts (+€30,719)
- Current investments +€75,394
new in 2025: €75,394
- Receivables within one year +€21,839
up €21,839 (+33.5%), from €65,218 to €87,057
of which Trade receivables: +€23,172
- Deferred charges and accrued income -€3,550
down €3,550 (-76.1%), from €4,663 to €1,113
- Reserves +€211,089
up €211,089 (+362.3%), from €58,264 to €269,353
- Tax, wage and social debts +€30,719
up €30,719 (+246.2%), from €12,475 to €43,194
- Trade debts -€20,845
down €20,845 (-91.2%), from €22,854 to €2,009
- Gross operating margin +€199,206
up €199,206 (+257.8%), from €77,276 to €276,481
- Taxes +€50,022
up €50,022 (+312.1%), from €16,027 to €66,049
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €98,685 | €320,255 | +€221,570 | +224.5% |
| Fixed assets | 21/28 | €747 | €3,808 | +€3,060 | +409.5% |
| Tangible fixed assets | 22/27 | €747 | €3,808 | +€3,060 | +409.5% |
| Furniture and vehicles | 24 | €747 | €3,808 | +€3,060 | +409.5% |
| Current assets | 29/58 | €97,937 | €316,447 | +€218,510 | +223.1% |
| Amounts receivable within one year | 40/41 | €65,218 | €87,057 | +€21,839 | +33.5% |
| Trade receivables | 40 | €63,885 | €87,057 | +€23,172 | +36.3% |
| Other amounts receivable | 41 | €1,333 | €0 | -€1,333 | -100.0% |
| Current investments | 50/53 | - | €75,394 | +€75,394 | |
| Cash at bank and in hand | 54/58 | €28,056 | €152,883 | +€124,827 | +444.9% |
| Deferred charges and accrued income | 490/1 | €4,663 | €1,113 | -€3,550 | -76.1% |
| Total equity and liabilities | 10/49 | €98,685 | €320,255 | +€221,570 | +224.5% |
| Equity | 10/15 | €60,764 | €271,853 | +€211,089 | +347.4% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €58,264 | €269,353 | +€211,089 | +362.3% |
| Distributable reserves | 133 | €58,264 | €269,353 | +€211,089 | +362.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €37,921 | €48,402 | +€10,481 | +27.6% |
| Amounts payable within one year | 42/48 | €37,921 | €48,402 | +€10,481 | +27.6% |
| Financial debts | 43 | €1,733 | €1,703 | -€30 | -1.7% |
| Credit institutions | 430/8 | €1,733 | €1,703 | -€30 | -1.7% |
| Trade debts | 44 | €22,854 | €2,009 | -€20,845 | -91.2% |
| Suppliers | 440/4 | €22,854 | €2,009 | -€20,845 | -91.2% |
| Taxes, remuneration and social security | 45 | €12,475 | €43,194 | +€30,719 | +246.2% |
| Taxes | 450/3 | €12,475 | €43,194 | +€30,719 | +246.2% |
| Other amounts payable | 47/48 | €859 | €1,496 | +€637 | +74.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €289 | €366 | +€77 | +26.7% |
| Other operating charges | 640/8 | €66 | €0 | -€66 | -100.0% |
| Gross operating margin | 9900 | €77,276 | €276,481 | +€199,206 | +257.8% |
| Operating profit (loss) | 9901 | €76,921 | €276,116 | +€199,195 | +259.0% |
| Financial income | 75/76B | €22 | €1,143 | +€1,122 | +5152.4% |
| Recurring financial income | 75 | €22 | €1,143 | +€1,122 | +5152.4% |
| Financial charges | 65/66B | €7 | €121 | +€115 | +1760.7% |
| Recurring financial charges | 65 | €7 | €121 | +€115 | +1760.7% |
| Profit (loss) for the period before taxes | 9903 | €76,936 | €277,138 | +€200,202 | +260.2% |
| Income taxes | 67/77 | €16,027 | €66,049 | +€50,022 | +312.1% |
| Profit (loss) for the period | 9904 | €60,909 | €211,089 | +€150,180 | +246.6% |
| Profit (loss) for the period to be appropriated | 9905 | €60,909 | €211,089 | +€150,180 | +246.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.